Covetrus

Covetrus Debt

Delisted

The Debt of Covetrus (CVET) as of Nov 20, 2026 is 1.05 B USD. In the previous year, Debt was 1.07 B USD — a change of -2.24% (lower).

Debt

1.05 BUSD

YoY

-2.24%

Last updated:

In 2021, Covetrus's total debt was 1.05 B USD, a -2.24% change from the 1.07 B USD total debt recorded in the previous year.

The Covetrus Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Debt
Date
Debt
Jan 1, 2016
26.90 M USD
Jan 1, 2017
26.73 M USD
Jan 1, 2018
24.20 M USD
Jan 1, 2019
1.19 B USD
Jan 1, 2020
1.07 B USD
Jan 1, 2021
1.05 B USD
The Covetrus Debt history
YEARDebtYoY
1.05 BUSD-2.24%
1.07 BUSD-9.86%
1.19 BUSD+4,804.15%
24.20 MUSD-9.46%
26.73 MUSD-0.62%
26.90 MUSD—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Covetrus Stock analysis

What does Covetrus do? Covetrus Inc is a global company specializing in providing services and products for veterinarians, animal clinics, and pet owners. It was formed in 2019 through a merger between the animal health divisions of Henry Schein and Vets First Choice. Covetrus traces its history back to 1856 when Henry Schein was founded as a small wholesale drug company. Over the years, the company expanded into new industries and markets. In the 2000s, Henry Schein began serving the animal health industry and established Vets First Choice in 2010 to offer a wider range of services and products to veterinarians and animal clinics. With the merger of Vets First Choice and Henry Schein's animal health division in 2019, Covetrus was created as a company with a broad spectrum of products and services for the animal health industry. Covetrus is headquartered in Portland, Maine, USA, and operates in over 25 countries. Its business model is based on providing services and products for veterinarians, animal clinics, and pet owners. The company is divided into several business segments, including diagnostics, pharmaceuticals, and consumables. In the diagnostics area, Covetrus offers a wide range of laboratory diagnostic services for veterinarians, including blood tests, imaging, fecal tests, and genetic tests. These test results help veterinarians diagnose and treat diseases in pets. In the pharmaceutical area, Covetrus offers veterinary medicines for various types of pets, including dogs, cats, and horses. These medicines are developed by leading pharmaceutical companies, and Covetrus provides veterinarians with a reliable supply chain for these products. The most recent business segment of Covetrus is the consumables area. Here, the company offers a wide range of products for veterinarians and animal clinics, including medical devices, surgical instruments, consumables for routine examinations, and more. In addition to these three main business segments, Covetrus also offers a variety of services, including practice management systems, training for veterinarians and animal clinics, financial services, and more. These services are designed to help veterinarians and animal clinics optimize their operations and improve their quality. The company has also developed a mobile application called 'Covetrus Connect' which provides veterinarians and animal clinics with an easier way to access products and services, place orders, and manage their operations. Overall, Covetrus is an innovative and rapidly growing company in the animal health industry. With a wide range of products and services tailored to the needs of veterinarians, animal clinics, and pet owners, the company is well-positioned to continue growing in this emerging market. Covetrus is one of the most popular companies on Eulerpool.

Debt Details

Understanding Covetrus's Debt Structure

Covetrus's total debt refers to the cumulative financial obligations the company owes to external parties. This can include short-term and long-term borrowings, bonds, loans, and other financial instruments. Assessing the company's debt levels is crucial for evaluating its financial health, risk profile, and ability to fund operations and expansions.

Year-to-Year Comparison

Analyzing Covetrus's debt structure over the years provides insights into the firm’s financial strategy and stability. A reduction in debt can indicate financial strength and operational efficiency, while an increase may signal growth investments or potential financial challenges ahead.

Impact on Investments

Investors pay close attention to Covetrus’s debt levels as they can influence the company’s risk and return profiles. Excessive debt can lead to financial strain, while moderate and well-managed debt can be a catalyst for growth and expansion, making it a critical aspect of investment evaluations.

Interpreting Debt Fluctuations

Shifts in Covetrus’s debt levels can be attributed to various operational and strategic factors. An increase in debt might be geared towards funding expansion projects or enhancing operational capacity, while a decrease may indicate profit realizations or an approach to minimize financial risk and leverage.

Frequently Asked Questions about Covetrus stock

Debt of Covetrus is 1.05 B USD in 2021.

Debt of Covetrus changed from 1.07 B USD to 1.05 B USD, representing a -2.24% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Debt Covetrus since 2006 – with annual values, charts, and detailed analysis.

Debt's USD is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Debt's Covetrus historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Covetrus

All Key Metrics — Covetrus